- Home
- RDI vs BEAT Comparison
RDI vs BEAT Comparison
Compare RDI & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDI | BEAT |
|---|---|---|
| Founded | 1937 | 2015 |
| Country | United States | United States |
| Employees | 2005 | 17 |
| Industry | Movies/Entertainment | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.4M | 27.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RDI | BEAT |
|---|---|---|
| Price | $1.51 | $0.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 40.6K | ★ 571.9K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.25 | N/A |
| Revenue Next Year | $4.04 | $315.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.94 | $0.48 |
| 52 Week High | $1.65 | $4.00 |
Technical Indicators
Market Signals| Indicator | RDI | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 67.55 | 37.54 |
| Support Level | $1.00 | N/A |
| Resistance Level | N/A | $0.70 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 100.00 | 21.13 |
Price Performance
Historical ComparisonAbout RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.